Genitourinary Malignancies Flashcards
1. Describe the most frequent clinical symptoms associated with each genitourinary malignancy (bladder, prostate, kidney and testicular cancer) (MKS1d). 2. Understand how staging impact the treatment plan and goals of genitourinary malignancies (MKS3d). 3. Identify patients at high risk for prostate cancer and its implication for screening strategies (MKS1f). 4. Understand the importance of androgen receptor signaling for prostate cancer growth at castrate levels of testosterone as a parad
What is the epidemiology of bladder cancer?
- Estimated new cases in 2015: 74,000 (M:F ratio – 3:1)
- Estimated deaths in 2014: 16,000
- Few clinical advances over the past 20 years
- Standard of care unchanged
- No targeted agents approved for bladder cancer
What are some risk factors of bladder carcinoma?
- Transitional cell epithelium
- Tumor primary sites: 90% bladder, 8% renal pelvis, 2% ureter and urethra
-
Risk factors
- Smoking (2-4x higher risk in smokers)
- Aniline dyes
- Drugs:
- phenacetin
- chlornaphazine
- cyclophosphamide
- Schistosoma haematobium
What are the pathological calssifications of bladder carcinoma?
- Transitional cell (95%)
- Squamous carcinoma (3%)
- Adenocarcinoma (2%)
- Small cell tumors (<1%)
- Others: melanoma, lymphoma
What are the signs and symptoms of bladder carcinoma?
- Hematuria (>80%)
- Irritative urinary symptoms:
- frequency, nocturia, urgency, precipitancy
- Flank pain
- Symptoms related to metastatic disease
What is the epidemiology of prostate cancer?
- Estimated new cases in 2015: 220,800
- Estimated deaths in 2015: 27,540
- Trend in cancer incidence: -2% /yr
- Positive trend in 5-year survival rates:
- 1975-77: 68%
- 1987-89: 83%
- 2004-10: >99%
How is PSA used in screening for prostate cancer?
-
American Cancer Society:
- PSA at 50 yo
- PSA < 2.5ng/ml: every 2 yrs testing
- PSA > 2.5ng/ml: annual
- Screening discussions 40-45 yo for high risk patients: African Americans and family history of 1st degree relative with prostate ca <65yo
- Biopsy if PSA > 4ng/ml
-
United State Preventive Services Task Force:
- Men should not be screened for prostate cancer
-
American Urological Association:
- PSA screening 55-69 yo
- Individualize decision for high risk patients (40-54 yo)
-
Do not screen:
- >70 yo
- Life expectancy < 10-15 yrs
-
American College of Physicians:
- Discuss with patients 50-69 yo
-
Do not screen:
- <50 or >69 yo
- Life expectancy < 10-15 yrs
Ehat are the signs and symptoms of prostate cancer?
- Urinary symptoms: urgency, nocturia, hesitancy
- Hematuria
- Back pain
What are the different pathological classifications of prostate cancer, and how are they graded/staged?
-
Evaluation and staging
- TRUS-guided needle biopsy
-
Pathology:
- Adenocarcinomas
- Squamous or transitional cell carcinoma
- Carcinosarcomas
- Metastatic tumors
- Gleason score
Ehat are the types of androgen depreivation therapy (ADT)?
- Surgery (orchiectomy)
- Injectable LHRH agonists (luprolide, goserelin)
- LHRH antagonists (degarelix)
- Antiandrogens (bicalutamide, flutamide, enzalutamide)
- Estrogens
What is the epidemiology of testicular cancer?
- Estimated new cases in 2015: 8,430
- Estimated deaths in 2015: 380
What are the types of testicular cancers and what are some risk factors?
- Primary germ cell tumors
- Patients 20-40 yrs old
-
Nonseminoma
- Embryonal carcinoma (AFP and/or hCG)
- Teratoma
- Choriocarcinoma (hCG)
- Endodermal sinus (yolk sac) (AFP)
- Seminoma
-
Other sites of primary germ cell tumors:
- mediastinum
- retroperitoneum
- pineal gland
-
Risk factors:
- Cryptorchidism
- Klinefelter’s syndrome
What are the signs and symptoms as well as diagnosis of testicular cancer?
-
Signs and symptoms
- Painless testicular mass
- Back pain
- Dyspnea
- Gynecomastia (hCG producing tumors)
-
Evaluation and staging
- Scrotal US
- Radical inguinal orchiectomy
- Alfa fetoprotein, hCG, LDH
- CT scan chest/abdomen/pelvis
What is the epidemiology of renal cell carcinoma?
- Estimated new cases in 2015: 61,560 (M:F ratio – 2:1)
- Estimated deaths in 2015: 14,080
- Positive trend in 5-year survival rates:
- 1975-77: 50%
- 1987-89: 57%
- 2004-10: 74% (to to increased imaging)
What are the risk factors of renal carcinoma?
- Smoking
- Acquired cystic disease associated end-stage kidney disease
- Tuberous sclerosis
- Genetic syndromes
What are the types of sporadic renal cell carcinoma?
- Clear cell - proximal tubule cell origin, most common
- Papillary - proximal tubule cell origin, bilateral and multifocal
- Chromophobic - cortical collecting duct cell origin, indolent
- Collecting duct - medullary collecting duct, aggressive and least common